Ricardo H Alvarez
Overview
Explore the profile of Ricardo H Alvarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krop I, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, et al.
J Clin Oncol
. 2023 Oct;
41(36):5550-5560.
PMID: 37801674
Purpose: Human epidermal growth factor receptor 3 (HER3) is broadly expressed in breast cancer; high expression is associated with an adverse prognosis. Patritumab deruxtecan (HER3-DXd) is an investigational HER3-targeted antibody-drug...
2.
Baghdadi T, Halabi S, Garrett-Mayer E, Mangat P, Ahn E, Sahai V, et al.
JCO Precis Oncol
. 2022 Feb;
3:1-8.
PMID: 35100714
Purpose: The Targeted Agent and Profiling Utilization Registry (TAPUR) Study identifies signals of antitumor activity of commercially available targeted agents in patients with advanced cancers that harbor genomic alterations known...
3.
Fisher J, Tait D, Garrett-Mayer E, Halabi S, Mangat P, Schink J, et al.
Target Oncol
. 2020 Oct;
15(6):733-741.
PMID: 33090333
Background: The Targeted Agent and Profiling Utilization Registry (TAPUR) Study, a phase II basket study, evaluates anti-tumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic...
4.
De Giorgi U, Mego M, Scarpi E, Giordano A, Giuliano M, Valero V, et al.
Ther Adv Med Oncol
. 2019 Aug;
11:1758835919866065.
PMID: 31452692
Background: We retrospectively evaluated the correlation between a baseline measurement of circulating tumor cells (CTCs) and inflammation-based scores in patients with metastatic breast cancer (MBC). Methods: The optimal value of...
5.
Cohen E, Fouad T, Lee B, Arun B, Liu D, Tin S, et al.
Breast Cancer Res Treat
. 2019 May;
176(3):545-556.
PMID: 31054033
Purpose: The carbohydrate sialyl Lewis (sLe) mediates cell adhesion, is critical in the normal function of immune cells, and is frequently over-expressed on cancer cells. We assessed the association, differential...
6.
Fouad T, Ueno N, Yu R, Ensor J, Alvarez R, Krishnamurthy S, et al.
PLoS One
. 2018 Sep;
13(9):e0204372.
PMID: 30248155
Background: To date, studies on inflammatory breast cancer (IBC) lack comprehensive epidemiological data. We analyzed detailed prospectively collected clinical and epidemiological data from the IBC Registry at The University of...
7.
Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez R, Willey J, et al.
JAMA Oncol
. 2018 Jun;
4(9):1207-1213.
PMID: 29879283
Importance: Combining conventional chemotherapy with targeted therapy has been proposed to improve the pathologic complete response (pCR) rate in patients with inflammatory breast cancer (IBC). Epidermal growth factor receptor (EGFR)...
8.
Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, Li C, et al.
Hum Pathol
. 2018 Apr;
77:121-129.
PMID: 29689244
Advanced-stage breast cancer patients comprise a smaller proportion of breast cancer patients than do early stage patients and are more likely to experience a poor outcome. Understanding the underlying molecular...
9.
Uemura M, French J, Hess K, Liu D, Raghav K, Hortobagyi G, et al.
Cancer
. 2018 Mar;
124(11):2299-2305.
PMID: 29579338
Background: Inflammatory breast cancer (IBC) is associated with a poor prognosis and high risk of central nervous system (CNS) metastases. Methods: We retrospectively reviewed stage III-IBC patients compared with noninflammatory...
10.
Alvarez R, Bechara R, Naughton M, Adachi J, Reuben J
Oncologist
. 2018 Mar;
23(6):660-669.
PMID: 29487226
Implications For Practice: This article summarizes the pathogenesis, clinical presentation, incidence, detection, and optimal management of everolimus-related noninfectious pneumonitis in breast cancer. In particular, this article provides a detailed overview...